Navigation Links
Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
Date:11/28/2007

EMERYVILLE, Calif., Nov. 28 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc (NTI (TM)) (Nasdaq: NTII) announced today that Warren Wasiewski, M.D. was appointed Chief Medical Officer, effective as of November 26, 2007.

Dr. Wasiewski joined NTI in February 2007 as Vice President, Clinical Programs with primary responsibility for running the clinical trial program for Viprinex(TM), NTI's drug candidate for acute ischemic stroke that is currently in two Phase 3 clinical trials. Dr. Wasiewski is a Board Certified Pediatric Neurologist with an extensive clinical career. Prior to joining NTI, he worked at AstraZeneca where he was Sr. Medical Director of clinical research CNS/Emerging Products. At AstraZeneca, Dr. Wasiewski had responsibility for running the global SAINT trials for AstraZeneca's neuroprotectant drug candidate.

Dr. Wasiewski holds a Bachelor of Arts degree in Biology Cum Laude from Rutgers College, a Masters of Science degree in Biochemistry from State University of New York Downstate Medical Center, and a Doctorate of Medicine from State University of New York, at Buffalo.

About Neurobiological Technologies, Inc.

NTI is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stage clinical trials for central nervous system conditions. The Company is currently developing Viprinex(TM) (ancrod), a novel reperfusion agent that is in pivotal Phase 3 trials for the treatment of acute ischemic stroke.


'/>"/>
SOURCE Neurobiological Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors
2. Governor Rendell Launches Tour to Insure in Warren County; Urges Passage of Plan to Give Access to Affordable Health Insurance
3. Friends of Warren Zevon To Play at Maverick Saloon - Raising Awareness of Asbestos Cancer, Mesothelioma
4. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
5. William Moore Appointed to IRIDEX Board of Directors
6. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
7. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
8. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
9. James B. Hawkins Appointed to IRIDEX Board of Directors
10. Bryan R. Rogers Appointed President of Far West Division
11. Catholic Health Association Disappointed by Failure to Override SCHIP Veto

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ov.25/PRNewswire-FirstCall/-- OnyxPharmaceuticals...llhosttwoinvestoreventsinDecember: ,, ASHBrie...ET ,, Principalinvestigatorswilldiscussdatapr...efractorymultiplemyeloma,asfeaturedatthe51stAmeric...oninNewOrleans,LA.Theteleconferencewillbeginat9:00...
(Date:11/25/2009)...RNewswire-USNewswire/--TheBlackAIDSInstituterecent...leadershipfor2010. ,, ThenewBoardMembersareahig...icy,law,finance,governmenthealthprograms,editorial...awiderangeofpersonalbackgroundsincludingbothhetero...selves,andrepresentingmultipleagegroups. ,, (Ph...
(Date:11/25/2009)...that grew out of a collaboration between UCLA engi...to the nearly 10 million Americans who suffer from...s hardening of the arteries, peripheral arterial d... which narrowed arteries reduce blood flow to the ...vascular disease, heart attack and stroke, and its...
(Date:11/25/2009)...d lead mothers to overlook needed care, study find...) -- A mother,s depression can worsen her child,s ...x-month study of 262 black mothers and their child...ressive symptoms had more frequent asthma symptoms...symptoms had less frequent asthma symptoms. , T...
(Date:11/25/2009)...Shownforthe4thStraightYear ,, WASHINGTON,Nov....nce-Georgia(LCA-GA)issuedthe 4thAnnualReportCardon...gmadeagainstthislethaldiseaseinthestateofGeorgia.L...tionalorganizationdedicatedexclusivelytopatientsup...ancer. ,, (Logo: http://www.newscom.com/cgi-bin...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
... activity is a major public health concern. Poor f...connected to heart disease and hypertension. Now a...also a risk factor for stroke. Cardiorespirato...d the Kuopio Research Institute of Exercise Medici...
Indian shopkeepers reported a plunge in sales of Coca-Cola and Pepsi soft drinks Friday and some put out banners to deter buyers in a growing scare after an environment group said the beverages conta
...ommonly used to lower cholesterol levels appear to...n unknown cause. The disease, known as idiopat...larged heart that doesn't pump properly. Unlike th...problems,// it is the number one reason people get...
... that revolutionized the treatment of anxiety and ... The drug owes its success to the stubborn strea...ter his boss at Hoffmann-La Roche ended a project ...d made animals relaxed and limp.// Sternbach ha...
... Hopkins University surgeons performed three simul...edical choreography that had nurses rushing organs...We each have a piece of each other inside us," sai...arily lucky,// six-way organ match among the patie...
...stress may worsen acne! Acne is a condition of t...gers and up to 25 percent of adults. While stres...claims have been unsubstantiated until now. Twenty...ns are common sources of stress for students. Stre...
Other Medicine News:Health News:Valium hits 40 years old, anxiety-free 2
(Date:11/24/2009)...wswire/-- ,, WHAT:RomHoubens,aBelgianmanthought...wasactuallyfullyconsciousandawakeduringthattimeand...oxEyeMaxwasfeaturedinthesegmenttoillustratehowpeop...communication. ,, WHEN:GoodMorningAmerica-- Tue...ch.com ,, WHO:RomHoubenswasanengineeringstu...
(Date:11/24/2009)...PRNewswire-FirstCall/--Vermillion,Inc.(VRML)(PinkS...anizationandDisclosureStatementtoday,November24,20...tofDelaware.AhearingtoconsiderapprovaloftheDisclos...withthehearingontheconfirmationofthePlanscheduledf...payallclaimsinfull.ThePlanisexpected,ifapproved,to...
(Date:11/24/2009)...ewswire/--Inadditiontofamily,friendsandhealth,canc...oherThanksgivinggratitudelist. ,, "Theyheardthe...saidofMonday,sverdictstotaling$103millionindamages...12,000womennationwidewhohavesuedWyethandPfizerphar...andPrempro.Wisneskiandtheothervictimsofhormonether...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Maryland Woman Thankful for Wyeth Verdicts 2InVitria Presents Zap CHO Performance Results at PEACe Conference 10054 1InVitria Presents Zap CHO Performance Results at PEACe Conference 10054 2Data Strategy Invited to Become a Member of VMware 26apos 3Bs Partner Technical Advisory Board 28PTAB 29 58123 1Data Strategy Invited to Become a Member of VMware 26apos 3Bs Partner Technical Advisory Board 28PTAB 29 58123 2Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 1Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 2Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 4Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 5Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 6
...Cell, Inc. presented the,results of a study conduc...d ApoCell at the 2007 annual meeting of the Americ...cago in early June.,The study showed that ApoCell,...ogy provides reliable predictive data of clinical,...g aggressive head,and neck cancer patients with a ...
...2007 - NuPathe Inc., a,privately held specialty ph...ults from an initial Phase I study of NP101,SmartR...developed,by NuPathe., NP101 combines NuPathe,s Sm...l technology with sumatriptan, the most,widely pre...,States. Sumatriptan is also the active ingredient...
Other Medicine Technology:ApoCell's Cancer Predictive Index Helps Oncologists Select the Most,Effective Targeted Drug Therapy 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 3
... a synonym for pipetting accuracy, a smooth stroke...ing comfort. Its single, multifunctional button is... as well as eject the tip. Product features: Epp...y and precision. Ejection sleeve can be removed t...
Pipetman P20
Hydro-Therm™ Small Volume HME with Flextube Patient Connection
...right product for any patient ranging from pediatr...nts with tracheotomies. These products offer super...l care applications., ,The Unti-Mist HME and HME/...d staff members. This entire product line of unti-...
Medicine Products: